Ashfaq Shuaib Selected Research

DP-b99

3/2013	Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.
8/2011	The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashfaq Shuaib Research Topics

Disease

123	Stroke (Strokes) 05/2024 - 02/2002
80	Ischemic Stroke 05/2024 - 02/2006
25	Infarction (Infarctions) 12/2022 - 02/2002
16	Ischemia 01/2023 - 02/2002
13	Hemorrhage 01/2024 - 02/2002
12	Atrial Fibrillation 01/2022 - 03/2003
11	Brain Ischemia (Cerebral Ischemia) 09/2008 - 02/2002
10	Transient Ischemic Attack 03/2024 - 02/2005
10	Hypertension (High Blood Pressure) 03/2024 - 06/2002
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2024 - 02/2002
9	Embolic Stroke 01/2020 - 04/2002
9	Brain Injuries (Brain Injury) 10/2009 - 04/2002
6	Vascular Diseases (Vascular Disease) 10/2020 - 07/2003
6	Cerebral Hemorrhage 08/2019 - 02/2002
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 07/2003
5	Thrombosis (Thrombus) 01/2024 - 01/2003
5	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2023 - 12/2002
5	Hyperthermia 01/2012 - 03/2005
4	Inflammation (Inflammations) 01/2023 - 06/2008
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 04/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 11/2010
3	Brain Infarction 01/2024 - 02/2003
3	Multiple Sclerosis 01/2023 - 01/2017
3	COVID-19 01/2022 - 01/2020
3	Pathologic Constriction (Stenosis) 12/2020 - 06/2015
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 08/2010
3	Diabetes Mellitus 11/2017 - 03/2013
3	Acute Coronary Syndrome 10/2013 - 03/2011
3	Brain Edema (Cerebral Edema) 04/2005 - 12/2002
3	Hypothermia 02/2003 - 04/2002
2	Obesity 03/2024 - 01/2022
2	Lacunar Stroke 03/2024 - 12/2022
2	Dementia (Dementias) 01/2023 - 01/2020
2	Atrophy 01/2023 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2017
2	Carotid Stenosis (Carotid Artery Stenosis) 12/2020 - 01/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 08/2002
2	Infections 01/2020 - 01/2019
2	Ganglion Cysts (Ganglion) 08/2019 - 01/2019
2	Edema (Dropsy) 07/2015 - 03/2005
2	Headache (Headaches) 10/2014 - 11/2008
2	Blood Vessel Dissection 10/2014 - 12/2003

Drug/Important Bio-Agent (IBA)

32	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 02/2002
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2009
14	Neuroprotective AgentsIBA 11/2014 - 02/2002
12	AnticoagulantsIBA 01/2023 - 12/2003
10	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 07/2003
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2019 - 07/2003
7	salicylhydroxamic acid (SHAM)IBA 01/2023 - 12/2002
6	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 01/2007
6	disufenton sodium (NXY 059)IBA 06/2008 - 02/2006
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2024 - 02/2002
5	Retinaldehyde (Retinal)IBA 01/2023 - 10/2014
5	Free RadicalsIBA 06/2008 - 02/2006
4	omega-Chloroacetophenone (Mace)IBA 03/2024 - 10/2020
4	Dabigatran FDA Link 05/2020 - 07/2014
4	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 07/2006
4	LipidsIBA 08/2017 - 06/2002
4	Blood Glucose (Blood Sugar)IBA 10/2015 - 06/2008
4	erucylphosphocholineIBA 11/2010 - 01/2005
3	Triglycerides (Triacylglycerol)IBA 03/2024 - 11/2018
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2024 - 07/2003
3	Cytidine Triphosphate (CTP)IBA 11/2023 - 01/2019
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2022
3	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
3	Plasminogen Activators (Plasminogen Activator)IBA 03/2020 - 04/2006
3	CholesterolIBA 01/2020 - 04/2010
3	RivaroxabanIBA 08/2019 - 01/2016
3	CreatinineIBA 08/2019 - 07/2003
3	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 03/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015 - 09/2008
3	Therapeutic UsesIBA 03/2013 - 02/2002
3	ZincIBA 03/2013 - 02/2004
3	Warfarin (Coumadin)FDA LinkGeneric 05/2011 - 03/2003
2	Tenecteplase FDA Link 02/2024 - 01/2024
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2022
2	milvexianIBA 01/2024 - 10/2022
2	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 10/2022
2	Messenger RNA (mRNA)IBA 12/2022 - 08/2002
2	C-Reactive ProteinIBA 12/2021 - 10/2009
2	Indicators and Reagents (Reagents)IBA 07/2019 - 04/2014
2	Antiviral Agents (Antivirals)IBA 01/2019 - 04/2005
2	Desmodus rotundus salivary plasminogen activator alpha 1IBA 12/2016 - 06/2015
2	Chelating AgentsIBA 03/2013 - 08/2011
2	DP-b99IBA 03/2013 - 08/2011
2	Laminin (Merosin)IBA 01/2012 - 05/2011
2	Proton Pump InhibitorsIBA 05/2011 - 03/2011

Therapy/Procedure

51	Therapeutics 05/2024 - 02/2002
8	Thrombectomy 05/2024 - 06/2016
8	Secondary Prevention 01/2022 - 06/2002
8	Thrombolytic Therapy 12/2021 - 03/2005
6	Time-to-Treatment 01/2020 - 03/2007
5	Length of Stay 01/2022 - 12/2015
4	Lasers (Laser) 01/2021 - 08/2010
3	Punctures 01/2024 - 06/2016
3	Activities of Daily Living (ADL) 01/2024 - 12/2006
3	Decompressive Craniectomy 01/2020 - 04/2019
2	Contraindications 08/2019 - 03/2013
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2011 - 03/2011